Measles Surge and New Mpox Strain Alarm Health Officials

Two Old Threats Return With a Vengeance

Public health officials are confronting a troubling convergence in early 2026: a record-breaking measles resurgence in the United States and the emergence of a genetically novel recombinant mpox virus. Together, these two outbreaks signal that diseases once considered under control are exploiting weaknesses in vaccination coverage and public health systems.

Measles Surges Across the United States

As of February 26, 2026, the Centers for Disease Control and Prevention had confirmed 1,136 measles cases across 28 US states — six times the typical annual total, and the country is only two months into the year. Ten active outbreaks are driving the surge, with roughly 90% of cases linked to community clusters where vaccination rates have dropped dangerously low.

South Carolina alone accounts for more than 650 cases, centred on Spartanburg County. Utah and Florida follow with 149 and 107 cases respectively. Critically, 96% of those infected were unvaccinated or had an unknown vaccination status, according to the CDC.

The consequences are already severe. Three people died from measles in 2025 — two children in Texas, one adult in New Mexico — all unvaccinated. CNN reported experts warning that, with current trajectory, deaths in 2026 are likely. For every 1,000 infected children, up to three may die and one may develop encephalitis.

The outbreak has triggered a geopolitical reckoning: the Pan American Health Organization (PAHO) issued an epidemiological alert and confirmed the Americas region has lost its measles-free status. The United States has held measles elimination status since 2000 — that designation is now under formal review.

A New Mpox Variant: When Two Clades Merge

Simultaneously, the World Health Organization has raised alarms over a newly identified recombinant mpox virus that combines genomic elements of both clade Ib — the aggressive strain fuelling outbreaks in Central Africa — and clade IIb, which drove the 2022 global emergency.

India notified WHO on January 13, 2026, of a patient whose symptoms dated back to September 2025. The same strain was later identified in a traveller in the United Kingdom who returned from the Asia-Pacific region in December 2025. As UN News reported, the Indian case now represents the earliest known detection of this recombinant strain globally.

The variant poses a particular diagnostic challenge: standard clade-differentiation PCR tests cannot reliably identify it. Whole-genome sequencing is required. WHO's current risk assessment keeps the threat at moderate for men who have sex with men and sex workers, and low for the general population — but urges all countries to maintain genomic surveillance.

The Systemic Failure Behind the Headlines

Experts are unequivocal: these outbreaks are not accidents. Writing in News-Medical, analysts argue the measles crisis reflects "weakened immunization policies, permissive exemptions, and underfunded public health systems" — not simply individual hesitancy.

The debunked 1998 study falsely linking the MMR vaccine to autism continues to circulate online and influence parental decisions. National MMR coverage among US kindergarteners has fallen below the critical 95% herd immunity threshold. In some communities, rates are far lower.

MIT Technology Review warns that measles may be the canary in the coal mine: declining vaccination rates put other vaccine-preventable diseases — mumps, hepatitis B, whooping cough — at risk of similar resurgences.

A Critical Juncture for Global Health

Two generations ago, measles killed millions annually worldwide. The near-eradication of the disease through vaccination was one of medicine's greatest achievements. That legacy is now being squandered. With a novel mpox strain evading standard diagnostics and measles reestablishing endemic transmission in the world's wealthiest hemisphere, the cost of vaccine hesitancy and public health neglect is becoming impossible to ignore.